Genome Ventures

Overview

Genome Ventures is a venture capital firm that partners with successful individuals and corporations to nurture innovative businesses from inception to exit. The firm provides investment, incubation, resources, and access to industry and technical assistance, with a primary focus on technologies that enable a more personalized approach to healthcare, education, and communication. Their portfolio includes companies such as genetic testing firm Genotek, children's development counseling platform Profilum, and corporate communications tool Tada.team. Established in 2015 and headquartered in Moscow, Russia, Genome Ventures operates as an accelerator, incubator, and venture capital firm. The firm specializes in early-stage investments, particularly in the Seed and Series B stages, and has a geographical focus on Russia, the United States, the United Arab Emirates, and the European Union. Their industry focus spans technology, healthcare, education, communication, EdTech, and smart city technology. Genome Ventures is led by founder Alexander Smbatyan, who also serves as an advisor to Moscow's deputy mayor. Under his leadership, the firm has supported companies that have expanded into international markets, including the U.S., UAE, and EU. The firm's approach combines traditional venture funding with comprehensive support to help portfolio companies achieve global reach and impact.

Investment Focus

• Innovative technology solutions in healthcare, education, and communication sectors
• Early-stage companies with potential for international expansion
• Teams with strong leadership and technical expertise

Portfolio Companies